Captor Capital Corp. (CPTR)

Overview

Captor Capital Corp. is a company that specializes in the retail sale of cannabis products within the United States. It initially operated under the name NWT Uranium Corp. before undergoing a rebranding to Captor Capital Corp. on June 2, 2017. The rebranding marked a significant pivot in the company’s focus from uranium exploration to the cannabis industry. Founded in 2003, the company is headquartered in Toronto, Canada, and has since established itself in the burgeoning cannabis market, leveraging the evolving legal and consumer landscape to cater to a growing demand for cannabis products.

Products and Services

Captor Capital Corp. offers a diverse range of products and services within the cannabis industry. These offerings are designed to meet the varied needs of their customer base, encompassing both recreational and medicinal users. The following are the primary categories of products and services provided by Captor Capital Corp.:

• Retail Cannabis:

  The cornerstone of Captor Capital Corp.’s offerings involves the retail sale of a variety of cannabis products. This includes a wide selection of cannabis strains, with varying levels of THC and CBD to cater to different preferences and needs. The product line extends to edibles, concentrates, topicals, and accessories, ensuring a comprehensive range of options for consumers.

• Medicinal Cannabis:

  Understanding the therapeutic potential of cannabis, Captor Capital Corp. also emphasizes the provision of medicinal cannabis products. This segment focuses on patients who require cannabis for medical purposes, offering products that are tailored for medical use with the appropriate concentrations of cannabinoids.